Andritsos, Leslie A <br/><br/>
Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia.  [electronic resource] 

 -  Leukemia & lymphoma  04 2018 
 - 1008-1011 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428194.2017.1365853  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Genes, Immunoglobulin Heavy Chain--genetics<br/>Humans<br/>Immunoglobulin Heavy Chains--genetics<br/>Immunoglobulin Variable Region--genetics<br/>Leukemia, Hairy Cell--drug therapy<br/>MAP Kinase Kinase 1--genetics<br/>Male<br/>Middle Aged<br/>Mutation<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyridones--therapeutic use<br/>Pyrimidinones--therapeutic use<br/>Treatment Outcome